Letters, Testimony & Comments

BIO submits letters, testimony, and comments to government and regulatory bodies throughout the United States and around the world.

Featured Letters, Testimony, & Comments
BIO Comment Letter – FDA-2026-D-1257 – Leveraging…
BIO Comment Letter – FDA-2026-D-1255 – Safety…
BIO Comment Letter – FDA-2026-N-2366 – CNPV Pilot…
All Letters, Testimony & Comments
  • Show All
Search
Results
March 10, 2016
Comments are regarding conservation and stewardship requirements, matching payments, establishment costs and annual payments, disclosure of competitively sensitive information, invasiveness determination and review, consistency with existing FSA…
March 10, 2016
Government's role in developing solutions for diseases that disproportionately affect developing countries
March 10, 2016
Mark Rohrbaugh, Director, Office of Technology Transfer, National Institutes of Health (NIH), US Department of Health & Human Services, USA
March 10, 2016
Innovation And The Global Research Enterprise WORLD HEALTH ORGANIZATION GENEVA—NOVEMBER 2007 THEODORE J. ROUMEL VICE PRESIDENT for RESEARCH, INNOVATION AND COMMERCIALIZATION UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE
March 10, 2016
More than 430 organizations representing American innovation in a wide range of industries in all 50 states wrote Senate leaders to express continued concern with S. 1145.
March 10, 2016
Biotechnology allows farmers to grow more food on less land using farming practices that are environmentally sustainable.
March 10, 2016
Read what experts are saying about biotech’s contributions to sustainability